NASDAQ Runners: Micron Technology (NASDAQ:MU), Zynga Inc (NASDAQ:ZNGA), FuelCell Energy Inc (NASDAQ:FCEL), Yahoo! Inc. (NASDAQ:YHOO)

TheStreet Ratings team rates MICRON TECHNOLOGY INC as a Buy with a ratings score of B. Micron Technology, Inc. (NASDAQ:MU) stock performance was -1.48% in last session and finished the day at $21.91. Traded volume was 37.76million shares in the last session and the average volume of the stock remained 31.44million shares. The beta of the stock remained 1.86. Micron Technology, Inc. (NASDAQ:MU) insider ownership … Continue reading NASDAQ Runners: Micron Technology (NASDAQ:MU), Zynga Inc (NASDAQ:ZNGA), FuelCell Energy Inc (NASDAQ:FCEL), Yahoo! Inc. (NASDAQ:YHOO)

Mid Cap Active Runners: Rite Aid Corporation (NYSE:RAD), Safeway Inc. (NYSE:SWY), Kinross Gold (NYSE:KGC), J.C. Penney Company (NYSE:JCP)

Two families were displaced and three stores were destroyed in a five-alarm fire in Jersey City early yesterday morning. Two firefighters suffered smoke inhalation and were sent to the Jersey City Medical Center, where they were treated and released, Jersey City Assistant Public Safety Director Jerry Cala said. The second floor of a Rite Aid Corporation (NYSE:RAD) Pharmacy at 337 Central Ave. and a vacant … Continue reading Mid Cap Active Runners: Rite Aid Corporation (NYSE:RAD), Safeway Inc. (NYSE:SWY), Kinross Gold (NYSE:KGC), J.C. Penney Company (NYSE:JCP)

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) announced the closing of its initial public offering of 3,263,010 ordinary shares at a public offering price of $13.50 per share, which included 425,610 ordinary shares issued upon the exercise in full of the underwriters’ option to purchase additional ordinary shares to cover over-allotments. Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) stock performance was -1.58% in last session and finished the day at $10.93. … Continue reading Biotech New Lows: Galmed Pharmaceuticals (NASDAQ:GLMD), Recro Pharma (NASDAQ:REPH), BioTime (NYSEMKT:BTX), Onconova Therapeutics (NASDAQ:ONTX)

Pfizer Inc. (NYSE:PFE) announced encouraging top-line data from a phase IIIb study evaluating Genotropin for increasing height in small-for-gestational-age (SGA) children aged between 24 and 30 months. Pfizer Inc. (NYSE:PFE) stock performance was -0.25% in last session and finished the day at $32.10. Traded volume was 27.74million shares in the last session and the average volume of the stock remained 26.63million shares. The beta of … Continue reading Healthcare Active Runners: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Inovio Pharmaceuticals (NYSEMKT:INO), Johnson & Johnson (NYSE:JNJ)

Earlier this week, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) announced that it has initiated a phase II pivotal study that will evaluate the safety and efficacy of AP26113 in locally advanced or metastatic non-small cell lung cancer (NSCLC) in patients who had previously been treated with Pfizer’s (PFE – Analyst Report) Xalkori (crizotinib). Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock performance was -1.16% in last session and finished the … Continue reading Biotech Active Movers: Ariad Pharmaceuticals (NASDAQ:ARIA), Insmed Incorporated (NASDAQ:INSM), Rexahn Pharmaceuticals (NYSEMKT:RNN), Inovio Pharmaceuticals (NYSEMKT:INO)

Pfizer Inc. (NYSE:PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Monday, May 5, 2014. Pfizer Inc. (NYSE:PFE) stock performance was 1.05% in last session and finished the day at $31.82. Traded volume was 21.09million shares in the last session and the average volume of the stock remained … Continue reading Healthcare Active Runners: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK)